Cargando…
Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma
Microvascular invasion (MVI) is presently evaluated as a high-risk factor to be directly relative to postoperative prognosis of hepatocellular carcinoma (HCC). Up to now, diagnosis of MVI mainly depends on the postoperative pathological analyses with H&E staining assay, based on numbers and dist...
Autores principales: | Cai, Yongchao, Fu, Yong, Liu, Changcheng, Wang, Xicheng, You, Pu, Li, Xiuhua, Song, Yanxiang, Mu, Xiaolan, Fang, Ting, Yang, Yang, Gu, Yuying, Zhang, Haibin, He, Zhiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873260/ https://www.ncbi.nlm.nih.gov/pubmed/35210426 http://dx.doi.org/10.1038/s41419-022-04625-y |
Ejemplares similares
-
Stathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinoma
por: Yurong, Lin, et al.
Publicado: (2016) -
Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma
por: Mao, Shuqi, et al.
Publicado: (2021) -
Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma
por: Tseng, Yi-Hsin, et al.
Publicado: (2016) -
Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma
por: Yu, Yuan-Quan, et al.
Publicado: (2016) -
Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
por: Kuang, Xia-Ying, et al.
Publicado: (2015)